These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6982500)

  • 1. Subpopulations of T lymphocytes in patients with chronic active liver disease.
    Burrai I; Carbone A
    Ric Clin Lab; 1982; 12(3):501-6. PubMed ID: 6982500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [T and B lymphocytes in hepatic diseases].
    Collazo L; Sotto A
    Acta Gastroenterol Latinoam; 1985; 15(1):7-12. PubMed ID: 3879074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferation and immunoglobulin synthesis of peripheral blood mononuclear cells from patients with chronic liver disease stimulated by Staphylococcus aureus Cowan 1 and interleukin 2.
    Kakumu S; Fuji A; Ohtani Y; Murase K; Hirofuji H; Tahara H
    Gastroenterol Jpn; 1987 Jun; 22(3):337-43. PubMed ID: 3114035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating immune complexes in chronic hepatitis as related to the presence of HBsAg.
    Radu D; Dumitraşcu D; Părău N; Urcan S; Stanciu L; Tăpălagă D; Ban A; Dumitraşcu D; Rusu C
    Med Interne; 1984; 22(1):61-5. PubMed ID: 6710050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of effector cells in lymphocytotoxicity to autologous hepatocytes in HBsAg-positive and autoimmune chronic active hepatitis (CAH).
    Barnaba V; Levrero M; Franco A; Ruberti G; Musca A; Bonavita MS; Balsano F
    Liver; 1986 Feb; 6(1):45-52. PubMed ID: 3487021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration in cell-mediated immunity in patients with chronic active hepatitis. I. Lymphocyte subpopulations.
    Ponzetto A; Arrigoni A
    G Batteriol Virol Immunol; 1979; 72(1-6):28-32. PubMed ID: 317950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of lymphocyte subpopulations in the liver tissue and blood of patients with chronic active hepatitis (CAH).
    Si LS; Whiteside TL; Schade RR; Van Thiel DH
    J Clin Immunol; 1983 Oct; 3(4):408-19. PubMed ID: 6606644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver disease in asymptomatic hepatitis B surface antigen carriers.
    Ng HS; Teh LB; Kwok KC; Ho J; Cheah E; Seah CS
    Ann Acad Med Singap; 1986 Apr; 15(2):145-8. PubMed ID: 3752891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma receptors on T cells in patients with chronic liver disease.
    Kakumu S; Yoshioka K; Fuji A; Tahara H
    Hepatogastroenterology; 1988 Aug; 35(4):158-61. PubMed ID: 2972598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and clinical significance of acetone-insoluble liver cell membrane antigen in sera of patients with chronic active liver diseases.
    Tsuji T; Takahashi K; Sawahara M; Matsuura E; Yamamoto I
    Gastroenterol Jpn; 1985 Feb; 20(1):37-47. PubMed ID: 4040488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Functional state of the T- and B-lymphocytes in children with chronic liver diseases].
    Mantasheva VA; Mikhaĭlova ZM; Chistova LV; Shkarenkova LV
    Pediatriia; 1980 Mar; (3):19-21. PubMed ID: 6966390
    [No Abstract]   [Full Text] [Related]  

  • 12. [The significance of immunological indicators in the diagnosis of chronic diseases of the liver].
    Iakhontova OI; Karashurova LL; Starkova SA
    Vrach Delo; 1988 Apr; (4):39-41. PubMed ID: 3261058
    [No Abstract]   [Full Text] [Related]  

  • 13. T and B lymphocytes in patients with chronic active liver disease and in healthy HBsAg carriers.
    Del Vecchio-Blanco C; Balzano A; Ambrogio G; Caporaso N; Bonanno G; Dente B
    Ric Clin Lab; 1980; 10(4):619-25. PubMed ID: 6970959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different levels of lymphocyte adenosine deaminase in active and inactive forms of chronic liver disease.
    Nardiello S; Russo M; Pizzella T; Galanti B
    J Clin Lab Immunol; 1983 Aug; 11(4):177-80. PubMed ID: 6608001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease in suppressor/cytotoxic T-cells with histamine receptors in patients with chronic active hepatitis.
    Colombo M; Rumi MG; Roffi L; Del Ninno E
    Liver; 1984 Jun; 4(3):201-7. PubMed ID: 6235426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HBsAg in the hepatocytes in chronic liver diseases].
    Loginov AS; Aruin LI; Shepeleva SD; Tkachev VD; Zotina MM
    Ter Arkh; 1986; 58(3):71-3. PubMed ID: 3715734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active rosette-forming lymphocytes in chronic hepatitis.
    Stanciu L; Urcan S; Părău N; Radu D; Popescu S
    Med Interne; 1982; 20(4):277-82. PubMed ID: 6985551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of activated gamma delta T cell receptor bearing T lymphocytes in patients with autoimmune chronic liver disease.
    Wen L; Peakman M; Mieli-Vergani G; Vergani D
    Clin Exp Immunol; 1992 Jul; 89(1):78-82. PubMed ID: 1385768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral T-cell subsets in chronic type B hepatitis: correlation with biochemical and histological activities and hepatitis B e antigen/antibody status.
    Chu CM; Liaw YF; Yang CY; Sheen IS
    Cell Immunol; 1984 Jul; 86(2):562-6. PubMed ID: 6234072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 2 receptor bearing T lymphocytes in patients with chronic liver disease.
    Kakumu S; Yoshioka K; Fuji A; Tahara H
    Gastroenterol Jpn; 1988 Aug; 23(4):408-13. PubMed ID: 3263293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.